Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gavi

- PMLiVE

J&J could launch its single-dose COVID-19 vaccine in March

Chief scientific officer Paul Stoffels said J&J is aiming for one billion doses in 2021

- PMLiVE

UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs

- PMLiVE

Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data

Updated data is lower than previously reported efficacy rate

- PMLiVE

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

CHMP could reach a decision on opinion by 29 January

- PMLiVE

BioNTech boosts COVID-19 vaccine capacity and aims to deliver 2 billion doses in 2021

Company will also publish data on vaccine's efficacy against new variants soon

- PMLiVE

New NHS COVID-19 vaccination centres open as cases surge in the UK

NHS is aiming to vaccinate around 15 million people by mid-February

- PMLiVE

UK approves Moderna’s COVID-19 vaccine, secures another 10 million doses

Total number of doses secured by UK now totals 17 million

- PMLiVE

Pfizer/BioNTech vaccine shown to be effective against new COVID-19 variants

Vaccine tested against variants discovered in the UK and South Africa

- PMLiVE

Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO

Moderna CEO Stéphane Bancel spoke at Oddo BHF event this week

- PMLiVE

Two drugs found to reduce mortality in severe COVID-19 patients

Actemra and Kevzara also improved recovery times among critically ill COVID-19 patients

- PMLiVE

CureVac and Bayer partner on mRNA-based COVID-19 vaccine

German pharma giant will support further development of CVnCoV

- PMLiVE

EMA recommends authorisation of Moderna’s COVID-19 vaccine

European Commission likely to formally approve the vaccine soon

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links